Skip to content
Evigrade
CriticalFirst-generation antipsychotics. Butyrophenone derivatives×Selective serotonin reuptake inhibitor (SSRI)

Updated · Methodology

Mechanism

Paroxetine strongly inhibits the enzyme CYP2D6 and raises the levels of CYP2D6 substrates that prolong the corrected QT interval (QTc). This may lengthen QTc further and cause torsade de pointes, other serious arrhythmias and sudden death (paroxetine label, US Food and Drug Administration, FDA). The liver clears haloperidol mainly by glucuronidation and ketone reduction. Of the cytochrome P450 enzymes, CYP3A4 and, to a lesser extent, CYP2D6 take part (haloperidol summary of product characteristics, SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). Paroxetine is on the list of CYP2D6 inhibitors that raise haloperidol levels: by 20–40% according to limited and sometimes conflicting data, and by up to 100% in some cases (haloperidol SmPC, AEMPS). The risk of QTc prolongation grows with haloperidol dose and plasma concentration. QTc increased when haloperidol was given with two metabolic inhibitors at once, ketoconazole 400 mg/day and paroxetine 20 mg/day (haloperidol SmPC, AEMPS, and haloperidol FDA label). Rarely, serotonin syndrome or neuroleptic malignant syndrome develops when paroxetine is combined with neuroleptics (paroxetine SmPC, AEMPS).

Symptoms

QT prolongation itself causes no symptoms and shows only on the electrocardiogram (ECG). Ventricular arrhythmias, including torsade de pointes, cause palpitations, dizziness and fainting. Ventricular arrhythmias and sudden death have been reported with haloperidol. Higher haloperidol levels strengthen its effects: tremor, muscle stiffness, excess salivation, slowed movement, restlessness (akathisia), acute muscle spasms (dystonia), fast heart rate and low blood pressure, including on standing up (haloperidol summary of product characteristics, SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). Neuroleptic malignant syndrome causes high fever, generalised muscle rigidity, unstable blood pressure and pulse, altered consciousness and raised creatine phosphokinase (haloperidol SmPC, AEMPS). Serotonin syndrome causes agitation, hallucinations, confusion, fast heart rate, labile blood pressure, sweating, fever, tremor, muscle jerks, seizures, nausea, vomiting and diarrhoea (paroxetine label, US Food and Drug Administration, FDA).

Management

The combination is contraindicated. In its September 2026 version, the US Food and Drug Administration (FDA) paroxetine label contraindicates paroxetine with drugs that prolong the QT interval and are CYP2D6 substrates, and haloperidol meets both conditions (paroxetine FDA label; haloperidol summary of product characteristics, SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). The Spanish SmPCs are softer: watch for signs of stronger haloperidol effects and lower its dose if needed (haloperidol SmPC, AEMPS), and use paroxetine with caution together with drugs that prolong QT (paroxetine SmPC, AEMPS). If the patient still takes both, record an electrocardiogram (ECG) before starting haloperidol and decide during treatment whether ECG monitoring is needed (haloperidol SmPC, AEMPS). Lower the haloperidol dose if the corrected QT interval (QTc) lengthens, and stop haloperidol if QTc exceeds 500 ms (haloperidol SmPC, AEMPS). Correct low potassium and magnesium before starting haloperidol and check electrolytes at baseline and periodically (haloperidol SmPC, AEMPS). Haloperidol inhibits CYP2D6, so consider the lowest paroxetine dose within the therapeutic range (haloperidol and paroxetine SmPCs, AEMPS). If serotonin syndrome or neuroleptic malignant syndrome appears, stop paroxetine and start supportive treatment (paroxetine SmPC, AEMPS). In neuroleptic malignant syndrome, stop haloperidol at once (haloperidol SmPC, AEMPS).

Your whole list in one report

Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email

Add more drugs

Medicine list: everything you take in one place →

Sources

Other interactions with Haloperidol

Other interactions with Paroxetine